Division of Endocrinology, Department of Pediatrics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Department of Health and Life Sciences Librarian, Nursing, Biomedical Library, University of California Los Angeles, Los Angeles, CA, USA.
Child Obes. 2024 Apr;20(3):208-218. doi: 10.1089/chi.2023.0005. Epub 2023 Apr 6.
Current treatment protocols to prevent and treat pediatric obesity focus on prescriptive lifestyle interventions. However, treatment outcomes are modest due to poor adherence and heterogeneity in responses. Wearable technologies offer a unique solution as they provide real-time biofeedback that could improve adherence to and sustainability of lifestyle interventions. To date, all reviews on wearable devices in pediatric obesity cohorts have only explored biofeedback from physical activity trackers. Hence, we conducted a scoping review to (1) catalog other biofeedback wearable devices available in this cohort, (2) document various metrics collected from these devices, and (3) assess safety and adherence to these devices. This scoping review was conducted adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews checklist. Fifteen eligible studies examined the use of biofeedback wearable devices beyond activity trackers in pediatric cohorts, with an emphasis on feasibility of these devices. Included studies varied in sample sizes (15-203) and in ages 6-21 years. Wearable devices are being used to capture various metrics of multicomponent weight loss interventions to provide more insights about glycemic variability, cardiometabolic function, sleep, nutrition, and body fat percentage. High safety and adherence rates were reported among these devices. Available evidence suggests that wearable devices have several applications aside from activity tracking, which could modify health behaviors through real-time biofeedback. Overall, these devices appear to be safe and feasible so as to be employed in various settings in the pediatric age group to prevent and treat obesity.
目前预防和治疗儿童肥胖的治疗方案侧重于规定的生活方式干预。然而，由于依从性差和反应异质性，治疗效果并不理想。可穿戴技术提供了一个独特的解决方案，因为它们提供实时生物反馈，从而可以提高对生活方式干预的依从性和可持续性。迄今为止，所有关于儿科肥胖队列中可穿戴设备的评论仅探讨了来自活动追踪器的生物反馈。因此，我们进行了范围综述，以：(1) 列出该队列中可用的其他生物反馈可穿戴设备，(2) 记录这些设备收集的各种指标，以及 (3) 评估这些设备的安全性和依从性。本范围综述遵循系统评价和荟萃分析扩展的首选报告项目清单进行。15 项合格研究检查了生物反馈可穿戴设备在儿科队列中的使用情况，除了活动追踪器之外，还重点关注这些设备的可行性。纳入的研究在样本量（15-203）和年龄（6-21 岁）方面存在差异。可穿戴设备用于捕获多组分减肥干预措施的各种指标，以提供有关血糖变异性、心脏代谢功能、睡眠、营养和体脂肪百分比的更多信息。这些设备报告了较高的安全性和依从率。现有证据表明，除了活动跟踪，可穿戴设备还有多种应用，通过实时生物反馈可以改变健康行为。总体而言，这些设备似乎是安全且可行的，因此可以在儿科年龄组的各种环境中使用，以预防和治疗肥胖症。
